No Data
No Data
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Warner Pharmaceutical Factory (688799.SH): The net income in the first half of the year is approximately 0.113 billion yuan, a year-on-year increase of 0.52%.
Glory August 30th | Warner Pharmaceutical Factory (688799.SH) announced that the revenue in the first half of 2024 was approximately 739 million yuan, an increase of 2.43% year-on-year; net income attributable to shareholders of the listed company was approximately 113 million yuan, an increase of 0.52% year-on-year; basic earnings per share was 1.2 yuan.
Warner Pharmaceutical Factory (688799.SH) released its half-year performance with a net income of 0.113 billion yuan, a year-on-year increase of 0.52%.
Warner Pharmaceutical Factory (688799.SH) released its semi-annual report for 2024, with a revenue of 0.739 billion yuan, ...
Warrant Pharmaceutical's Unit Gets Nod to Trial Psoriasis Drug
Warner Pharmaceutical Factory (688799.SH): ZG-002 tablets have obtained the Notice of Approval for Clinical Trial of Drugs.
Warner Pharmaceutical Factory (688799.SH) announced that its holding subsidiary, Shanghai Zhigen Medical Technology Co., Ltd...
No Data
No Data